Ilyang Pharmaceutical Co.,Ltd 007570.KS Stock
Ilyang Pharmaceutical Co.,Ltd Price Chart
Ilyang Pharmaceutical Co.,Ltd 007570.KS Financial and Trading Overview
Ilyang Pharmaceutical Co.,Ltd stock price | 13920 KRW |
Previous Close | 17300 KRW |
Open | 17330 KRW |
Bid | 17590 KRW x 0 |
Ask | 17610 KRW x 0 |
Day's Range | 17330 - 17650 KRW |
52 Week Range | 16130 - 25800 KRW |
Volume | 23.68K KRW |
Avg. Volume | 36.73K KRW |
Market Cap | 318.15B KRW |
Beta (5Y Monthly) | -0.081849 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 150 (0.85%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
007570.KS Valuation Measures
Enterprise Value | 425.91B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.840691 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.125 |
Enterprise Value/EBITDA | 9.068 |
Trading Information
Ilyang Pharmaceutical Co.,Ltd Stock Price History
Beta (5Y Monthly) | -0.081849 |
52-Week Change | -22.24% |
S&P500 52-Week Change | 20.43% |
52 Week High | 25800 KRW |
52 Week Low | 16130 KRW |
50-Day Moving Average | 17539.2 KRW |
200-Day Moving Average | 18435 KRW |
007570.KS Share Statistics
Avg. Volume (3 month) | 36.73K KRW |
Avg. Daily Volume (10-Days) | 27.7K KRW |
Shares Outstanding | 18.09M |
Float | 13.01M |
Short Ratio | N/A |
% Held by Insiders | 26.60% |
% Held by Institutions | 3.57% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.1732 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.26% |
Operating Margin (ttm) | 8.88% |
Gross Margin | 54.76% |
EBITDA Margin | 12.41% |
Management Effectiveness
Return on Assets (ttm) | 4.56% |
Return on Equity (ttm) | 9.43% |
Income Statement
Revenue (ttm) | 378.44B KRW |
Revenue Per Share (ttm) | 20911.55 KRW |
Quarterly Revenue Growth (yoy) | -6.29% |
Gross Profit (ttm) | 215.85B KRW |
EBITDA | 46.97B KRW |
Net Income Avi to Common (ttm) | 15.68B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -51.60% |
Balance Sheet
Total Cash (mrq) | 14.95B KRW |
Total Cash Per Share (mrq) | 826.66 KRW |
Total Debt (mrq) | 90.96B KRW |
Total Debt/Equity (mrq) | 35.67 KRW |
Current Ratio (mrq) | 0.847 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 19.63B KRW |
Levered Free Cash Flow (ttm) | -12279872512 KRW |
Profile of Ilyang Pharmaceutical Co.,Ltd
Country | South Korea |
State | N/A |
City | Yongin |
Address | 110, Hagal-ro |
ZIP | 17096 |
Phone | 82 3 1281 7851 |
Website | https://www.ilyang.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 640 |
Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products to approximately 14 countries. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin, South Korea.
Q&A For Ilyang Pharmaceutical Co.,Ltd Stock
What is a current 007570.KS stock price?
Ilyang Pharmaceutical Co.,Ltd 007570.KS stock price today per share is 13920 KRW.
How to purchase Ilyang Pharmaceutical Co.,Ltd stock?
You can buy 007570.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ilyang Pharmaceutical Co.,Ltd?
The stock symbol or ticker of Ilyang Pharmaceutical Co.,Ltd is 007570.KS.
Which industry does the Ilyang Pharmaceutical Co.,Ltd company belong to?
The Ilyang Pharmaceutical Co.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ilyang Pharmaceutical Co.,Ltd have in circulation?
The max supply of Ilyang Pharmaceutical Co.,Ltd shares is 17.97M.
What is Ilyang Pharmaceutical Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Ilyang Pharmaceutical Co.,Ltd PE Ratio is now.
What was Ilyang Pharmaceutical Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Ilyang Pharmaceutical Co.,Ltd EPS is 0 KRW over the trailing 12 months.
Which sector does the Ilyang Pharmaceutical Co.,Ltd company belong to?
The Ilyang Pharmaceutical Co.,Ltd sector is Healthcare.